A 66‑year‑old patient’s death in Andhra Pradesh is attributed to multiple underlying conditions rather than COVID‑19 alone. Meanwhile, three fresh infections have been identified in Mangalagiri and Visakhapatnam.

मुख्य बिंदु (Key Takeaways)

  • 66‑year‑old’s death linked to comorbidities, not solely COVID‑19
  • Two new cases in Mangalagiri, one in Visakhapatnam
  • Authorities remain vigilant as the state monitors a possible resurgence

Andhra Pradesh has recorded its third COVID‑19 related death, alongside three newly confirmed positive cases. The latest fatality follows two earlier deaths in the state, underscoring the need for heightened vigilance as the virus shows signs of re‑emergence.

Details of the Fatal Case

According to the state Health Department, the deceased was a 66‑year‑old man suffering from chronic respiratory issues, pneumonia, diabetes, hypertension and kidney disease. He tested positive on July 3 and was admitted sequentially to the Rajiv Gandhi Institute of Medical Sciences in Kadapa, then to the Sri Venkateswara Institute of Medical Sciences (SWIMS) in Tirupati, and finally to a private hospital. He passed away on July 15. Officials emphasized that the death was not caused by COVID‑19 alone but by the combination of his numerous comorbidities.

New Positive Cases

Two patients have been admitted to AIIMS, Mangalagiri, while a third case is under treatment at King George Hospital (KGH) in Visakhapatnam. All three reported typical symptoms—fever, body aches and breathlessness—but detailed travel histories remain undisclosed.

Political Angle

A politician who traveled to Hyderabad in early July tested positive on July 12 after developing fever and respiratory discomfort. He is currently receiving care at KGH, Visakhapatnam, and his condition is described as stable.

Broader Implications

Earlier in the month, two COVID‑19 deaths were reported—one in YSR Kadapa district and another in Annamayya district. Andhra Pradesh has conducted over 1.2 million tests to date, yet the trajectory of new infections remains a point of debate among epidemiologists. Experts stress that vaccination, mask usage, and social distancing remain critical tools to curb any potential surge.